These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29680411)

  • 21. Changes in cytogenetics and molecular genetics in acute myeloid leukemia from childhood to adult age groups.
    Creutzig U; Zimmermann M; Reinhardt D; Rasche M; von Neuhoff C; Alpermann T; Dworzak M; Perglerová K; Zemanova Z; Tchinda J; Bradtke J; Thiede C; Haferlach C
    Cancer; 2016 Dec; 122(24):3821-3830. PubMed ID: 27529519
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytogenetic Profiles of 472 Indian Children with Acute Myeloid Leukemia.
    Tyagi A; Pramanik R; Chaudhary S; Chopra A; Bakhshi S
    Indian Pediatr; 2018 Jun; 55(6):469-473. PubMed ID: 29978812
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Genetic prognostic factors in childhood acute myeloid leukemia].
    Reinhardt D; Von Neuhoff C; Sander A; Creutzig U
    Klin Padiatr; 2012 Oct; 224(6):372-6. PubMed ID: 22821298
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Karyotype is an independent prognostic parameter in therapy-related acute myeloid leukemia (t-AML): an analysis of 93 patients with t-AML in comparison to 1091 patients with de novo AML.
    Schoch C; Kern W; Schnittger S; Hiddemann W; Haferlach T
    Leukemia; 2004 Jan; 18(1):120-5. PubMed ID: 14586477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy.
    Tsimberidou AM; Kantarjian HM; Estey E; Cortes JE; Verstovsek S; Faderl S; Thomas DA; Garcia-Manero G; Ferrajoli A; Manning JT; Keating MJ; Albitar M; O'Brien S; Giles FJ
    Leukemia; 2003 Jun; 17(6):1100-3. PubMed ID: 12764375
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extramedullary leukemia in children with newly diagnosed acute myeloid leukemia: a report from the Children's Cancer Group.
    Dusenbery KE; Howells WB; Arthur DC; Alonzo T; Lee JW; Kobrinsky N; Barnard DR; Wells RJ; Buckley JD; Lange BJ; Woods WG
    J Pediatr Hematol Oncol; 2003 Oct; 25(10):760-8. PubMed ID: 14528097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute Myeloid Leukemia With t(v;5q33) Is Associated With Poor Overall Survival and Often Lacks Myelodysplastic Features.
    Yabe M; Tang G; Garcia-Manero G; Loghavi S; Lu X; Miranda RN; Medeiros LJ; Kantarjian HM; Bueso-Ramos CE; Khoury JD
    Clin Lymphoma Myeloma Leuk; 2015 Jun; 15 Suppl():S85-90. PubMed ID: 26297286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apoptosis: A biomarker of high-risk phenotype in pediatric acute myeloid leukemia?
    Tyagi A; Pramanik R; Bakhshi R; Vishnubhatla S; Bakhshi S
    Int J Lab Hematol; 2019 Feb; 41(1):141-147. PubMed ID: 30383325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minimally differentiated acute myeloid leukemia (FAB AML-M0) is associated with an adverse outcome in children: a report from the Children's Oncology Group, studies CCG-2891 and CCG-2961.
    Barbaric D; Alonzo TA; Gerbing RB; Meshinchi S; Heerema NA; Barnard DR; Lange BJ; Woods WG; Arceci RJ; Smith FO
    Blood; 2007 Mar; 109(6):2314-21. PubMed ID: 17158236
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical, molecular, and prognostic significance of WHO type inv(3)(q21q26.2)/t(3;3)(q21;q26.2) and various other 3q abnormalities in acute myeloid leukemia.
    Lugthart S; Gröschel S; Beverloo HB; Kayser S; Valk PJ; van Zelderen-Bhola SL; Jan Ossenkoppele G; Vellenga E; van den Berg-de Ruiter E; Schanz U; Verhoef G; Vandenberghe P; Ferrant A; Köhne CH; Pfreundschuh M; Horst HA; Koller E; von Lilienfeld-Toal M; Bentz M; Ganser A; Schlegelberger B; Jotterand M; Krauter J; Pabst T; Theobald M; Schlenk RF; Delwel R; Döhner K; Löwenberg B; Döhner H
    J Clin Oncol; 2010 Aug; 28(24):3890-8. PubMed ID: 20660833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Superior outcome of pediatric acute myeloid leukemia patients with orbital and CNS myeloid sarcoma: a report from the Children's Oncology Group.
    Johnston DL; Alonzo TA; Gerbing RB; Lange BJ; Woods WG
    Pediatr Blood Cancer; 2012 Apr; 58(4):519-24. PubMed ID: 21618422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic factors in adult patients up to 60 years old with acute myeloid leukemia and translocations of chromosome band 11q23: individual patient data-based meta-analysis of the German Acute Myeloid Leukemia Intergroup.
    Krauter J; Wagner K; Schäfer I; Marschalek R; Meyer C; Heil G; Schaich M; Ehninger G; Niederwieser D; Krahl R; Büchner T; Sauerland C; Schlegelberger B; Döhner K; Döhner H; Schlenk RF; Ganser A
    J Clin Oncol; 2009 Jun; 27(18):3000-6. PubMed ID: 19380453
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extramedullary leukemia in children with acute myeloid leukemia: A population-based cohort study from the Nordic Society of Pediatric Hematology and Oncology (NOPHO).
    Støve HK; Sandahl JD; Abrahamsson J; Asdahl PH; Forestier E; Ha SY; Jahnukainen K; Jónsson ÓG; Lausen B; Palle J; Zeller B; Hasle H
    Pediatr Blood Cancer; 2017 Dec; 64(12):. PubMed ID: 28333413
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics and prognostic factors of acute myeloid leukemia with t (8; 21) (q22; q22).
    Lai YY; Qiu JY; Jiang B; Lu XJ; Huang XJ; Zhang Y; Liu YR; Shi HL; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):733-40. PubMed ID: 16277833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low miR-192 expression predicts poor prognosis in pediatric acute myeloid leukemia.
    Tian C; Zhang L; Li X; Zhang Y; Li J; Chen L
    Cancer Biomark; 2018; 22(2):209-215. PubMed ID: 29689705
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trisomy 8 in pediatric acute myeloid leukemia: A NOPHO-AML study.
    Laursen AC; Sandahl JD; Kjeldsen E; Abrahamsson J; Asdahl P; Ha SY; Heldrup J; Jahnukainen K; Jónsson ÓG; Lausen B; Palle J; Zeller B; Forestier E; Hasle H
    Genes Chromosomes Cancer; 2016 Sep; 55(9):719-26. PubMed ID: 27153159
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High receptor tyrosine kinase (FLT3, KIT) transcript versus anti-apoptotic (BCL2) transcript ratio independently predicts inferior outcome in pediatric acute myeloid leukemia.
    Sharawat SK; Bakhshi R; Vishnubhatla S; Bakhshi S
    Blood Cells Mol Dis; 2015 Jan; 54(1):56-64. PubMed ID: 25216797
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Monosomal karyotype is not a predictor of dismal outcome in childhood de novo acute myeloid leukemia.
    Lee NH; Choi YB; Yi ES; Lee SH; Kim HJ; Lee JW; Sung KW; Koo HH; Yoo KH
    Leuk Res; 2016 Nov; 50():57-62. PubMed ID: 27683973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outcome of Adolescents and Young Adults Compared With Pediatric Patients With Acute Myeloid and Promyelocytic Leukemia.
    Nasir SS; Giri S; Nunnery S; Martin MG
    Clin Lymphoma Myeloma Leuk; 2017 Feb; 17(2):126-132.e1. PubMed ID: 27836483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic significance of the EVI1 gene expression in patients with acute myeloid leukemia: a meta-analysis.
    Wu X; Wang H; Deng J; Zheng X; Ling Y; Gong Y
    Ann Hematol; 2019 Nov; 98(11):2485-2496. PubMed ID: 31482295
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.